Page last updated: 2024-08-21

benzoxazoles and Leukemia, Myeloid

benzoxazoles has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreeff, M; Coombes, K; Fruman, DA; Jessen, K; Kantarjian, HM; Konopleva, M; Kornblau, SM; Liu, Y; Mak, DH; Qiu, YH; Rommel, C; Wang, RY; Yoo, SY; Zeng, Z; Zhang, Q	1

Other Studies

1 other study(ies) available for benzoxazoles and Leukemia, Myeloid

Article	Year
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells. Oncotarget, 2016, Aug-23, Volume: 7, Issue:34 Topics: Acute Disease; Animals; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leukemia, Myeloid; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplastic Stem Cells; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases; U937 Cells; Xenograft Model Antitumor Assays	2016

Article

Year

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells.

Oncotarget, 2016, Aug-23, Volume: 7, Issue:34

Topics: Acute Disease; Animals; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leukemia, Myeloid; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplastic Stem Cells; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases; U937 Cells; Xenograft Model Antitumor Assays

2016